| 1025818-02-3 |
|
4-(5-Bromomethyl-4,5-dihydro-isoxazol-3-yl)-phenylamine |
C10H11BrN2O |
| 102582-69-4 |
8-Hydroxypinoresinol-4′-O-β-D-glucopyranoside |
8-Hydroxypinoresinol-4′-O-β-D-glucopyranoside |
C26H32O12 |
| 102582-93-4 |
对三氟甲硫基苯乙酸 |
4-(TRIFLUOROMETHYLTHIO)PHENYLACETIC ACID |
C9H7F3O2S |
| 1025821-33-3 |
GSK-626616 |
GSK-626616 |
C18H10Cl2N4OS |
| 1025822-61-0 |
|
1,4-Benzenedicarboxaldehyde, 2-methoxy |
C9H8O3 |
| 1025825-38-0 |
反式-3-甲氧基-1-丙烯基三氟硼酸钾 |
PotassiuM (E)-3-Methoxyprop-1-enyltrifluoroborate |
C4H7BF3KO |
| 1025828-21-0 |
3-氧代氮杂烷-1-羧酸苄酯 |
Benzyl 3-oxoazepane-1-carboxylate |
C14H17NO3 |
| 102583-47-1 |
Validamycin B |
Validamycin B |
C20H35NO14 |
| 102583-65-3 |
|
stendomycin A |
|
| 102583-71-1 |
|
ZZL 0810 (9CI) |
|
| 102583-95-9 |
|
Benzoic acid, 2-[[3-chloro-5-(trifluoromethyl)phenyl]amino] |
C14H9ClF3NO2 |
| 102583-96-0 |
|
2-[[2,5-bis(trifluoromethyl)phenyl]amino]benzoic acid |
C15H9F6NO2 |
| 102584-42-9 |
|
BRN 0276172 |
C20H24ClNO |
| 102584-43-0 |
1-Cyclohexyl-3-(diphenylmethoxy)pyrrolidine |
1-Cyclohexyl-3-(diphenylmethoxy)pyrrolidine |
C23H29NO |
| 102584-86-1 |
|
1,1'-(p-Xylylene)bis[3-(1-aziridinyl)urea] |
C14H20N6O2 |
| 102584-88-3 |
|
5-(nitrosocyanamido)-2-hydroxyvaleramide |
C13H25N3O4 |
| 102585-22-8 |
|
2-[bis(2-chloroethyl)amino]acetaldehyde |
C6H11Cl2NO |
| 102585-27-3 |
|
ACETALDEHYDE, (((1-NAPHTHYL)METHYLENE)AMINO)-, DIETHYLACETAL |
|
| 102585-31-9 |
|
Acetamide, N-(2-bromo-2-propen-1-yl)-N-butyl |
C9H16BrNO |
| 102585-91-1 |
|
5-(2-Hydroxy-3-iodopropyl)-5-isopropyl-2,4,6(1H,3H,5H)-pyrimidinetrione |
C10H15IN2O4 |
| 1025855-68-8 |
|
N-cyclopentyl-N-(3-oxo-2,3-dihydro-1H-inden-1-yl)acetamide |
C16H19NO2 |
| 102586-21-0 |
|
Phenethylamine, N-benzyl-beta-(dimethylamino)-alpha-ethyl |
C19H26N2 |
| 102586-30-1 |
CS-2161 |
NSC-12 |
C24H34F6O3 |
| 102586-88-9 |
|
1,5-Ethano-2H-1-benzazepin-2-one, 1,3,4,5-tetrahydro |
C12H13NO |
| 102586-93-6 |
|
4-Quinolinepropanoic acid, 1,2,3,4-tetrahydro |
C12H15NO2 |
| 102587-08-6 |
|
2H-Pyran-2-one, 3-(bromomethyl)-5-(trifluoromethyl) |
C7H4BrF3O2 |
| 102587-42-8 |
N-(3,4-二氯苯)-4-氟苯甲酰胺 |
N-(3,4-dichlorophenyl)-4-fluorobenzamide |
C13H8Cl2FNO |
| 102587-50-8 |
|
2-CYCLOBUTYLAMINO-4-ETHYLAMINO-6-CHLORO-1,3,5-TRIAZINE |
C9H14ClN5 |
| 102587-98-4 |
2,7-二溴芘 |
2,7-Dibromopyrene |
C16H8Br2 |
| 1025870-92-1 |
|
Butanoic acid, 4-(dimethylamino)-2-methylene |
C7H13NO2 |
| 1025877-03-5 |
Milbemycin Impurity 3 |
Milbemycin Impurity 3 |
C31 H43 N O7 |
| 1025881-27-9 |
雪花胺莰酸酯 |
(-)-Galanthaminyl (-)-Camphanate |
C27H33NO6 |
| 1025882-24-9 |
4-[3-(甲硫基)苯基]-1-丙基-1,2,3,6-四氢吡啶 |
4-[3-(Methylsulfanyl)phenyl]-1-propyl-1,2,3,6-tetrahydro-pyridine |
C15H21NS |
| 1025885-73-7 |
|
Benzene, 1-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-(iodomethyl) |
C14H23IOSi |
| 102589-20-8 |
|
4,6-Pyrimidinediamine, N4-(2-furanylmethyl) |
C9H10N4O |
| 102589-30-0 |
Bicyclo[2.2.2]octa-2,5-diene-2-carboxylic acid (6CI,9CI) |
Bicyclo[2.2.2]octa-2,5-diene-2-carboxylic acid (6CI,9CI) |
C9H10O2 |
| 1025892-26-5 |
五氘代苯甲酰基甲酸乙酯 |
Ethyl Benzoylformate-d5 |
C10H5D5O3 |
| 1025894-97-6 |
|
1,3-Benzenedicarboxylic acid, 4-(6-amino-3-imino-4,5-disulfo-3H-xanthen-9-yl)-, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
C25H17N3O13S2 |
| 10259-08-2 |
|
NCA |
C8H13NO3 |
| 10259-14-0 |
2,6-二(三氘甲基)吡啶 |
2,6-Litidine-d6 |
C7H3D6N |
| 10259-15-1 |
吡啶-D1 |
pyridine-4-d1 |
C5H4DN |
| 10259-17-3 |
3-甲基吡啶-D3 |
3-(2H3)Methylpyridine |
C6H4D3N |
| 10259-18-4 |
4-皮考林-甲基-D3 |
4-PICOLINE-METHYL-D3 |
C6H4D3N |
| 10259-19-5 |
2-甲基吡啶-D3 |
2-(2H3)Methyl(2H4)pyridine |
C6D7N |
| 10259-22-0 |
3-甲氧基苯甲酸乙酯 |
ETHYL 3-METHOXYBENZOATE |
C10H12O3 |
| 102590-73-8 |
|
Benzenamine, N-(3-ethyl-4,5-diphenyl-2(3H)-oxazolylidene) |
C23H20N2O |
| 1025902-17-3 |
INDEX NAME NOT YET ASSIGNED |
|
C16H11ClO4 |
| 1025903-60-9 |
|
Benzothiazole, 6-bromo-7-chloro-2-methyl |
C8H5BrClNS |
| 1025904-00-0 |
5-(氯甲基)喹喔啉 |
5-(ChloroMethyl)quinoxaline |
C9H7ClN2 |
| 1025905-33-2 |
|
Spiro[piperidine-4,1'-[1H]pyrido[3,4-b]indole], 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-7'-fluoro-2',3',4',9'-tetrahydro |
C21H19ClF4N4 |
中文
